XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2025
OPERATING ACTIVITIES      
(Loss)/Profit for the period $ (7,448,232) $ (6,198,053)  
Adjustments to reconcile profit to net cash flows      
Income tax 2,082,995 (1,266,409)  
Financial results 12,572,783 9,833,069  
Depreciation of property, plant and equipment 1,530,447 1,524,370  
Amortization of intangible assets 3,248,270 3,026,403  
Depreciation of leased assets 1,052,983 760,728  
Restructuring and transactional expenses 642,844    
Share-based incentive and stock options 533 809,585  
Share of profit or loss of joint ventures and associates (296,772) 586,318  
Provisions for contingencies 33,451 297,159  
Allowance for impairment of trade debtors 655,034 184,879  
Allowance for obsolescence 457,274 614,618  
Initial recognition and changes in the fair value of biological assets (160,540) (666,175)  
Changes in the net realizable value of agricultural products after harvest 340,072 (563,145)  
Gain on sale of equipment and intangible assets 2,602 (326,561)  
Working capital adjustments      
Trade receivables 5,400,597 11,318,922  
Other receivables (1,082,399) (5,362,397)  
Income and minimum presumed income taxes (1,693,562) (2,470,954)  
Inventories and biological assets (451,257) 7,438,097  
Trade and other payables (2,873,750) (17,603,938)  
Employee benefits and social security (649,989) 1,000,042  
Deferred revenue and advances from customers (1,560,916) 1,744,616  
Interest collected 2,555,154 435,469  
Inflation effects on working capital adjustments 19,365 40,182  
Net cash flows generated by operating activities 14,376,987 5,156,825  
INVESTMENT ACTIVITIES      
Proceeds from sale of property, plant and equipment   336,726  
Proceeds from financial assets 160,544 5,813,446  
Investment in financial assets (53,983) (2,738,959)  
Purchase of property, plant and equipment (672,115) (1,278,332)  
Capitalized development expenditures (668,297) (1,654,017)  
Purchase of intangible assets (30,214) (207,101)  
Net cash flows (used by)/generated by investing activities (1,264,065) 271,763  
FINANCING ACTIVITIES      
Proceeds from borrowings 11,845,324 39,888,252  
Repayment of borrowings and financed payments (34,843,516) (51,585,854)  
Interest payments (3,854,103) (4,808,496)  
Other financial payments (566,451) (1,102,617)  
Leased assets payments (1,291,338) (1,189,615)  
Net cash flows used by financing activities (28,710,084) (18,798,330)  
Net decrease in cash and cash equivalents (15,597,162) (13,369,742)  
Inflation effects on cash and cash equivalents (44) (21)  
Cash and cash equivalents as of beginning of the period 32,695,079 44,473,270 $ 44,473,270
Effect of exchange rate changes on cash and equivalents (1,592,727) 1,174,904  
Cash and cash equivalents as of the end of the period $ 15,505,146 $ 32,278,411 $ 32,695,079